Filing Impact
Filing Sentiment
Form Type
4
Iqvia Hldgs Inc
Sep 2, 2025
IQVIA Announces CFO Transition in Early 2026
Aug 18, 2025
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
Aug 18, 2025
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
Jul 22, 2025
IQVIA Reports Second-Quarter 2025 Results
Sep 2, 2025
[8-K] IQVIA Holdings Inc. Reports Material Event
Aug 14, 2025
[SCHEDULE 13G/A] IQVIA Holdings Inc. SEC Filing
31.29B
168.21M
1.05%
102.09%
4%
Diagnostics & Research
Services-commercial Physical & Biological Research
United States
DURHAM